PRESS RELEASE published on 01/19/2024 at 14:40, 1 year 2 months ago United Health Products Reports on FDA Application Status United Health Products (UEEC) reports on the receipt and review of final reports on product sterilization and stability testing for its hemostatic gauze as part of its FDA application process. The reported data on the efficacy of the proposed radiation sterilization protocol were well within acceptable bioburden levels for Class III products, and the company will proceed with final drafting of the PMA documentation for submission. The press release raises awareness about the company's ongoing FDA application status and its pursuit of approval for its hemostatic products. United Health Products UEEC FDA Application Status Hemostatic Gauze Premarket Approval Application
Published on 04/04/2025 at 00:00, 23 minutes ago Onco-Innovations' Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025
Published on 04/03/2025 at 15:05, 9 hours 18 minutes ago Snowline Gold Closes Fully Subscribed C$20 Million Financing Of Flow-Through Shares
Published on 04/03/2025 at 15:00, 9 hours 23 minutes ago Kingstone Insurance Partners with Kyber Technologies Inc.
Published on 04/03/2025 at 15:00, 9 hours 23 minutes ago UniDoc Announces Debt Settlement and Renews Marketing Engagement
Published on 04/03/2025 at 15:00, 9 hours 23 minutes ago Xebra Brands’ Largest Shareholder Increases Stake as Company Explores Landmark Agricultural Agreement in Mexico
Published on 04/03/2025 at 18:46, 5 hours 36 minutes ago Monthly disclosure of the total number of shares and voting rights - March 2025
Published on 04/03/2025 at 18:46, 5 hours 36 minutes ago Déclaration mensuelle des actions et droits de vote – Mars 2025
Published on 04/03/2025 at 18:00, 6 hours 23 minutes ago LDC : Chiffre d'affaires 2024-2025 : 6,3 milliards d’euros, au-delà des objectifs.
